Truist Securities analyst Richard Newitter reiterated a Buy rating and $28.00 price target on Beta Bionics, Inc. (NASDAQ: BBNX).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE